Blockage Reversal Evidence

Scientific Literature (Published Evidence)

 Multiple well-conducted scientific trials have demonstrated the effectiveness of blockage reversal. Let’s delve into the evidence:

1. Whole Food Plant-Based Diet and Blockage Reversal

In 1995, Caldwell Esselstyn from Cleveland, America, published the results of a ground breaking study showcasing the power of a whole food plant-based diet in reversing blockages. The study revealed significant angiographic reversal of blockages through diet control alone. This evidence was reinforced in a larger trial of 198 patients in 2014, where intensive counselling led to a dietary compliance rate of 87%.

2. Lifestyle Changes and Blockage Reversal

Dean Ornish from California, America, published his findings in 1998 on the impact of intensive lifestyle changes in reversing coronary heart disease. This randomized controlled trial involved 48 patients who underwent an intervention consisting of a vegetarian diet, exercise, stress management training, smoking cessation, and group psychosocial support for five years. The results showed notable blockage reversal in the intervention group, with greater reversal observed after five years compared to one year. Conversely, the control group experienced blockage progression and a higher incidence of heart attacks during follow-up.

3. Statin Drugs and Blockage Reversal

The REVERSAL trial was the first to demonstrate the halting of blockage progression with high-dose Atorvastatin. The intervention arm achieved an average LDL level of 79 mg/dL. Subsequent trials, including ASTEROID, SATURN, and PRECISE IVUS, collectively enrolled over 1500 patients. These studies demonstrated blockage reversal using either Rosuvastatin 40 mg or Atorvastatin 80 mg, achieving LDL levels of 63 mg/dL in the intervention groups.

4. PCSK9 Monoclonal Antibodies Injections and Blockage Reversal

PCSK9 inhibitors are potent injections capable of lowering LDL levels by 80% to 85%. The GLAGOV, HUYGENS, and PACMAN AMI randomized trials collectively enrolled 1500 patients. These trials demonstrated significant blockage reversal, as assessed by plaque area volume regression in the intervention arms. The LDL levels were impressively reduced to between 23 and 36 mg/dL.

For more detailed information and references, please visit our website: (